Receptor Tyrosine Kinase Signaling Networks Define Sensitivity to ERBB Inhibition and Stratify Kras Mutant Lung Cancers

Sarang S. Talwelkar, Ashwini S. Nagaraj, Jennifer R. Devlin, Annabrita Hemmes, Swapnil Potdar, Elina A. Kiss, Pipsa Saharinen, Kaisa Maria Salmenkivi, Mikko I. Mäyränpää, Krister Wennerberg, Emmy Verschuren

Research output: Contribution to journal › Article › Scientific › peer-review

Original languageEnglish
JournalMolecular Cancer Therapeutics
ISSN1535-7163
DOIs
Publication statusE-pub ahead of print - 2019
MoE publication typeA1 Journal article-refereed

Cite this

Talwelkar, Sarang S. ; Nagaraj, Ashwini S. ; Devlin, Jennifer R. ; Hemmes, Annabrita ; Potdar, Swapnil ; Kiss, Elina A. ; Saharinen, Pipsa ; Salmenkivi, Kaisa Maria ; Mäyränpää, Mikko I. ; Wennerberg, Krister ; Verschuren, Emmy. / Receptor Tyrosine Kinase Signaling Networks Define Sensitivity to ERBB Inhibition and Stratify Kras Mutant Lung Cancers. In: Molecular Cancer Therapeutics. 2019.
@article{931a61720a5f4bfb98fba0ffdd3859b5,
title = "Receptor Tyrosine Kinase Signaling Networks Define Sensitivity to ERBB Inhibition and Stratify Kras Mutant Lung Cancers",
author = "Talwelkar, {Sarang S.} and Nagaraj, {Ashwini S.} and Devlin, {Jennifer R.} and Annabrita Hemmes and Swapnil Potdar and Kiss, {Elina A.} and Pipsa Saharinen and Salmenkivi, {Kaisa Maria} and M{\"a}yr{\"a}np{\"a}{\"a}, {Mikko I.} and Krister Wennerberg and Emmy Verschuren",
year = "2019",
doi = "10.1158/1535-7163.MCT-18-0573",
language = "English",
journal = "Molecular Cancer Therapeutics",
issn = "1535-7163",
publisher = "American Association for Cancer Research",

}

Talwelkar, SS, Nagaraj, AS, Devlin, JR, Hemmes, A, Potdar, S, Kiss, EA, Saharinen, P, Salmenkivi, KM, Mäyränpää, MI, Wennerberg, K & Verschuren, E 2019, 'Receptor Tyrosine Kinase Signaling Networks Define Sensitivity to ERBB Inhibition and Stratify Kras Mutant Lung Cancers', Molecular Cancer Therapeutics. https://doi.org/10.1158/1535-7163.MCT-18-0573

Receptor Tyrosine Kinase Signaling Networks Define Sensitivity to ERBB Inhibition and Stratify Kras Mutant Lung Cancers. / Talwelkar, Sarang S.; Nagaraj, Ashwini S.; Devlin, Jennifer R.; Hemmes, Annabrita; Potdar, Swapnil; Kiss, Elina A.; Saharinen, Pipsa; Salmenkivi, Kaisa Maria; Mäyränpää, Mikko I.; Wennerberg, Krister; Verschuren, Emmy.

In: Molecular Cancer Therapeutics, 2019.

Research output: Contribution to journal › Article › Scientific › peer-review

TY - JOUR

T1 - Receptor Tyrosine Kinase Signaling Networks Define Sensitivity to ERBB Inhibition and Stratify Kras Mutant Lung Cancers

AU - Talwelkar, Sarang S.

AU - Nagaraj, Ashwini S.

AU - Devlin, Jennifer R.

AU - Hemmes, Annabrita

AU - Potdar, Swapnil

AU - Kiss, Elina A.

AU - Saharinen, Pipsa

AU - Salmenkivi, Kaisa Maria

AU - Mäyränpää, Mikko I.

AU - Wennerberg, Krister

AU - Verschuren, Emmy

PY - 2019

Y1 - 2019

U2 - 10.1158/1535-7163.MCT-18-0573

DO - 10.1158/1535-7163.MCT-18-0573

M3 - Article

JO - Molecular Cancer Therapeutics

JF - Molecular Cancer Therapeutics

SN - 1535-7163

ER -

Talwelkar SS, Nagaraj AS, Devlin JR, Hemmes A, Potdar S, Kiss EA et al. Receptor Tyrosine Kinase Signaling Networks Define Sensitivity to ERBB Inhibition and Stratify Kras Mutant Lung Cancers. Molecular Cancer Therapeutics. 2019. https://doi.org/10.1158/1535-7163.MCT-18-0573

Access to Document